Homepage

A unique development company for drug delivery patches

Medherant is developing the 1st in class TEPI Patch

Perfect patches for patients

TEPI Patch creates significant USPs for our customers' medicines

Medherant is creating a sustainable, next-generation transdermal drug delivery patch company that creates value for patients, partners and investors. We develop new applications for patch technology that have not been possible before. The company, a spin-out from the University of Warwick, is developing TEPI Patch®, a higher-dosage drug delivery patch with a constant rate of drug release.

Ibuprofen Patch

Medherant is developing an ibuprofen transdermal patch using its TEPI Patch technology.